PT - 141 10mg

PT-141 (Bremelanotide) is a synthetic peptide and melanocortin receptor agonist. Unlike therapies that primarily target vascular blood flow, PT-141 acts directly on the central nervous system. It works by binding to melanocortin receptors (specifically MC3R and MC4R) in the brain, which are neural pathways associated with the regulation of sexual desire and arousal.

• Not FDA-Approved: Compounded medications are customized for individual patients and are not FDA-approved finished drug products.

• Patient-Specific: Dispensed only pursuant to a valid, patient-specific prescription from a licensed healthcare provider based on a documented clinical need.

• No Brand Equivalence: This compounded preparation is not represented as an exact copy or equivalent to commercially available brand-name medications.